Gabapentin
NDC 82619-143, Gabapentin, capsule, from Creekwood Pharmaceuticals LLC.
- Product NDC
- 82619-143
- Status
- Listed
- Labeler
- Creekwood Pharmaceuticals LLC
- Dosage form
- CAPSULE
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA204989
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/82619-143 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- GABAPENTIN300 mg/1
Pharmacologic classes
Decreased Central Nervous System Disorganized Electrical Activity [PE]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 82619-143-01 | 82619014301 | 100 CAPSULE in 1 BOTTLE (82619-143-01) |
| 82619-143-02 | 82619014302 | 500 CAPSULE in 1 BOTTLE (82619-143-02) |
| 82619-143-03 | 82619014303 | 1000 CAPSULE in 1 BOTTLE (82619-143-03) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/26aac429-a5cd-33cc-e063-6394a90aecc0
Use it
Look up 82619-143 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/82619-143 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 82619-143. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.